Literature DB >> 23620545

Proteome-derived peptide libraries to study the substrate specificity profiles of carboxypeptidases.

Sebastian Tanco1, Julia Lorenzo, Javier Garcia-Pardo, Sven Degroeve, Lennart Martens, Francesc Xavier Aviles, Kris Gevaert, Petra Van Damme.   

Abstract

Through processing peptide and protein C termini, carboxypeptidases participate in the regulation of various biological processes. Few tools are however available to study the substrate specificity profiles of these enzymes. We developed a proteome-derived peptide library approach to study the substrate preferences of carboxypeptidases. Our COFRADIC-based approach takes advantage of the distinct chromatographic behavior of intact peptides and the proteolytic products generated by the action of carboxypeptidases, to enrich the latter and facilitate its MS-based identification. Two different peptide libraries, generated either by chymotrypsin or by metalloendopeptidase Lys-N, were used to determine the substrate preferences of human metallocarboxypeptidases A1 (hCPA1), A2 (hCPA2), and A4 (hCPA4). In addition, our approach allowed us to delineate the substrate specificity profile of mouse mast cell carboxypeptidase (MC-CPA or mCPA3), a carboxypeptidase suggested to function in innate immune responses regulation and mast cell granule homeostasis, but which thus far lacked a detailed analysis of its substrate preferences. mCPA3 was here shown to preferentially remove bulky aromatic amino acids, similar to hCPA2. This was also shown by a hierarchical cluster analysis, grouping hCPA1 close to hCPA4 in terms of its P1 primed substrate specificity, whereas hCPA2 and mCPA3 cluster separately. The specificity profile of mCPA3 may further aid to elucidate the function of this mast cell carboxypeptidase and its biological substrate repertoire. Finally, we used this approach to evaluate the substrate preferences of prolylcarboxypeptidase, a serine carboxypeptidase shown to cleave C-terminal amino acids linked to proline and alanine.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23620545      PMCID: PMC3734572          DOI: 10.1074/mcp.M112.023234

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  63 in total

1.  PRIDE: the proteomics identifications database.

Authors:  Lennart Martens; Henning Hermjakob; Philip Jones; Marcin Adamski; Chris Taylor; David States; Kris Gevaert; Joël Vandekerckhove; Rolf Apweiler
Journal:  Proteomics       Date:  2005-08       Impact factor: 3.984

Review 2.  Methods for mapping protease specificity.

Authors:  Scott L Diamond
Journal:  Curr Opin Chem Biol       Date:  2006-12-06       Impact factor: 8.822

3.  The role of the S1 binding site of carboxypeptidase M in substrate specificity and turn-over.

Authors:  Kathleen Deiteren; Georgiana Surpateanu; Kambiz Gilany; Johan L Willemse; Dirk F Hendriks; Koen Augustyns; Yves Laroche; Simon Scharpé; Anne-Marie Lambeir
Journal:  Biochim Biophys Acta       Date:  2006-12-08

4.  Nna1-like proteins are active metallocarboxypeptidases of a new and diverse M14 subfamily.

Authors:  Monica Rodriguez de la Vega; Rafael G Sevilla; Antoni Hermoso; Julia Lorenzo; Sebastian Tanco; Amalia Diez; Lloyd D Fricker; José M Bautista; Francesc X Avilés
Journal:  FASEB J       Date:  2007-01-23       Impact factor: 5.191

5.  Snake bites and bee stings: the mast cell strikes back.

Authors:  Juan Rivera
Journal:  Nat Med       Date:  2006-09       Impact factor: 53.440

6.  Template-based modeling and free modeling by I-TASSER in CASP7.

Authors:  Yang Zhang
Journal:  Proteins       Date:  2007

7.  Caught after the Act: a human A-type metallocarboxypeptidase in a product complex with a cleaved hexapeptide.

Authors:  Alex Bayés; Daniel Fernández; Maria Solà; Aniebrys Marrero; Sonia García-Piqué; Francesc X Avilés; Josep Vendrell; F Xavier Gomis-Rüth
Journal:  Biochemistry       Date:  2007-05-17       Impact factor: 3.162

Review 8.  Metallocarboxypeptidases: emerging drug targets in biomedicine.

Authors:  Joan L Arolas; Josep Vendrell; Francesc X Aviles; Lloyd D Fricker
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

9.  Purification and characterization of a carboxypeptidase from squid hepatopancreas (Illex illecebrosus).

Authors:  R Raksakulthai; N F Haard
Journal:  J Agric Food Chem       Date:  2001-10       Impact factor: 5.279

10.  Comparative substrate specificity study of carboxypeptidase U (TAFIa) and carboxypeptidase N: development of highly selective CPU substrates as useful tools for assay development.

Authors:  Johan L Willemse; Magnus Polla; Thomas Olsson; Dirk F Hendriks
Journal:  Clin Chim Acta       Date:  2007-09-22       Impact factor: 3.786

View more
  17 in total

1.  Quantitative Multiplex Substrate Profiling of Peptidases by Mass Spectrometry.

Authors:  John D Lapek; Zhenze Jiang; Jacob M Wozniak; Elena Arutyunova; Steven C Wang; M Joanne Lemieux; David J Gonzalez; Anthony J O'Donoghue
Journal:  Mol Cell Proteomics       Date:  2019-01-31       Impact factor: 5.911

2.  PRIME-XS, a European infrastructure for proteomics.

Authors:  Reinout Raijmakers; Jesper V Olsen; Ruedi Aebersold; Albert J R Heck
Journal:  Mol Cell Proteomics       Date:  2014-06-23       Impact factor: 5.911

3.  Identification of Protease Specificity by Combining Proteome-Derived Peptide Libraries and Quantitative Proteomics.

Authors:  Martin L Biniossek; Melanie Niemer; Ken Maksimchuk; Bettina Mayer; Julian Fuchs; Pitter F Huesgen; Dewey G McCafferty; Boris Turk; Guenther Fritz; Jens Mayer; Georg Haecker; Lukas Mach; Oliver Schilling
Journal:  Mol Cell Proteomics       Date:  2016-04-27       Impact factor: 5.911

4.  C-terminomics screen for natural substrates of cytosolic carboxypeptidase 1 reveals processing of acidic protein C termini.

Authors:  Sebastian Tanco; Olivia Tort; Hans Demol; Francesc Xavier Aviles; Kris Gevaert; Petra Van Damme; Julia Lorenzo
Journal:  Mol Cell Proteomics       Date:  2014-11-07       Impact factor: 5.911

5.  Prolylcarboxypeptidase deficiency is associated with increased blood pressure, glomerular lesions, and cardiac dysfunction independent of altered circulating and cardiac angiotensin II.

Authors:  Christoph Maier; Ines Schadock; Philipp K Haber; Jan Wysocki; Minghao Ye; Yashpal Kanwar; Christopher A Flask; Xin Yu; Brian D Hoit; Gregory N Adams; Alvin H Schmaier; Michael Bader; Daniel Batlle
Journal:  J Mol Med (Berl)       Date:  2017-02-03       Impact factor: 4.599

Review 6.  Carboxypeptidases in disease: insights from peptidomic studies.

Authors:  Matthew R Sapio; Lloyd D Fricker
Journal:  Proteomics Clin Appl       Date:  2014-03-24       Impact factor: 3.494

7.  Global analysis of cellular proteolysis by selective enzymatic labeling of protein N-termini.

Authors:  Arun P Wiita; Julia E Seaman; James A Wells
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

8.  Crystal structure and mechanism of human carboxypeptidase O: Insights into its specific activity for acidic residues.

Authors:  Maria C Garcia-Guerrero; Javier Garcia-Pardo; Esther Berenguer; Roberto Fernandez-Alvarez; Gifty B Barfi; Peter J Lyons; Francesc X Aviles; Robert Huber; Julia Lorenzo; David Reverter
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-10       Impact factor: 11.205

9.  Lung Mast Cells Have a High Constitutive Expression of Carboxypeptidase A3 mRNA That Is Independent from Granule-Stored CPA3.

Authors:  Premkumar Siddhuraj; Carl-Magnus Clausson; Caroline Sanden; Manar Alyamani; Mohammad Kadivar; Jan Marsal; Joanna Wallengren; Leif Bjermer; Jonas S Erjefält
Journal:  Cells       Date:  2021-02-03       Impact factor: 6.600

10.  Novel carboxypeptidase A6 (CPA6) mutations identified in patients with juvenile myoclonic and generalized epilepsy.

Authors:  Matthew R Sapio; Monique Vessaz; Pierre Thomas; Pierre Genton; Lloyd D Fricker; Annick Salzmann
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.